» Articles » PMID: 12138163

The Recombinant Human TRPV6 Channel Functions As Ca2+ Sensor in Human Embryonic Kidney and Rat Basophilic Leukemia Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Jul 26
PMID 12138163
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The activation mechanism of the recently cloned human transient receptor potential vanilloid type 6 (TRPV6) channel, originally termed Ca(2+) transporter-like protein and Ca(2+) transporter type 1, was investigated in whole-cell patch-clamp experiments using transiently transfected human embryonic kidney and rat basophilic leukemia cells. The TRPV6-mediated currents are highly Ca(2+)-selective, show a strong inward rectification, and reverse at positive potentials, which is similar to store-operated Ca(2+) entry in electrically nonexcitable cells. The gating of TRPV6 channels is strongly dependent on the cytosolic free Ca(2+) concentration; lowering the intracellular free Ca(2+) concentration results in Ca(2+) influx, and current amplitude correlates with the intracellular EGTA or BAPTA concentration. This is also the case for TRPV6-mediated currents in the absence of extracellular divalent cations; compared with endogenous currents in nontransfected rat basophilic leukemia cells, these TRPV6-mediated monovalent currents reveal differences in reversal potential, inward rectification, and slope at very negative potentials. Release of stored Ca(2+) by inositol 1,4,5-trisphosphate and/or the sarco/endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin appears not to be involved in TRPV6 channel gating in both cell lines but, in rat basophilic leukemia cells, readily activates the endogenous Ca(2+) release-activated Ca(2+) current. In conclusion, TRPV6, expressed in human embryonic kidney cells and in rat basophilic leukemia cells, functions as a Ca(2+)-sensing Ca(2+) channel independently of procedures known to deplete Ca(2+) stores.

Citing Articles

Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein.

Neuberger A, Trofimov Y, Yelshanskaya M, Nadezhdin K, Krylov N, Efremov R Nat Commun. 2023; 14(1):2659.

PMID: 37160865 PMC: 10169861. DOI: 10.1038/s41467-023-38352-5.


Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy.

Sharma A, Ramena G, Elble R Biomedicines. 2021; 9(9).

PMID: 34572262 PMC: 8466575. DOI: 10.3390/biomedicines9091077.


Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors.

Baio G, Fabbi M, Cilli M, Rosa F, Boccardo S, Valdora F PLoS One. 2020; 15(9):e0224414.

PMID: 32931488 PMC: 7491733. DOI: 10.1371/journal.pone.0224414.


Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells.

Arbabian A, Iftinca M, Altier C, Singh P, Isambert H, Coscoy S Channels (Austin). 2020; 14(1):101-109.

PMID: 32186440 PMC: 7153789. DOI: 10.1080/19336950.2020.1740506.


TRPV6 as A Target for Cancer Therapy.

Stewart J J Cancer. 2020; 11(2):374-387.

PMID: 31897233 PMC: 6930427. DOI: 10.7150/jca.31640.